CIK 0001721484 · <br>Emerging growth company
Longeveron Inc.
Sign in to watch- Ticker
- LGVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 472174146
- Phone
- 305-302-7158
- Business address
- 1951 NW 7TH AVENUE, SUITE 520, MIAMI, FL, 33136
- Former names
- LONGEVERON LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-01 | Locklear Lisa Chief Financial Officer | Shares withheld for taxes | −22,505 | $0.73 | $16K | 443,181 |
| 2026-07-01 | Agafonova Nataliya Chief Medical Officer | Shares withheld for taxes | −22,505 | $0.73 | $16K | 430,914 |
| 2026-07-01 | Blass Devin CTO & SVP of CMC | Shares withheld for taxes | −15,808 | $0.73 | $12K | 425,735 |
| 2026-07-01 | Lehr Paul T General Counsel, Secretary | Shares withheld for taxes | −13,143 | $0.73 | $10K | 575,423 |
| 2026-05-01 | Lehr Paul T General Counsel, Secretary | Grant or award | +250,000 | 588,566 | ||
| 2026-05-01 | Willard Stephen H Chief Executive Officer | Grant or award | +500,000 | 789,727 | ||
| 2026-05-01 | Blass Devin CTO & SVP of CMC | Grant or award | +250,000 | 441,543 | ||
| 2026-05-01 | Agafonova Nataliya Chief Medical Officer | Grant or award | +250,000 | 453,419 | ||
| 2026-05-01 | Locklear Lisa Chief Financial Officer | Grant or award | +250,000 | 465,686 | ||
| 2026-04-01 | Lehr Paul T General Counsel, Secretary | Shares withheld for taxes | −5,611 | $1.12 | $6K | 338,566 |
| 2026-04-01 | Agafonova Nataliya Chief Medical Officer | Shares withheld for taxes | −13,145 | $1.12 | $15K | 203,419 |
| 2026-04-01 | Locklear Lisa Chief Financial Officer | Shares withheld for taxes | −13,145 | $1.12 | $15K | 215,686 |
| 2026-04-01 | Willard Stephen H Chief Executive Officer | Shares withheld for taxes | −4,740 | $1.12 | $5K | 289,727 |
| 2026-04-01 | Blass Devin CTO & SVP of CMC | Shares withheld for taxes | −8,633 | $1.12 | $10K | 191,543 |
| 2026-03-02 | Willard Stephen H Chief Executive Officer | Grant or award | +200,000 | 200,000 | ||
| 2026-03-02 | Willard Stephen H Chief Executive Officer | Shares withheld for taxes | −105,533 | $0.55 | $58K | 94,467 |
| 2026-03-02 | Willard Stephen H Chief Executive Officer | Grant or award | +200,000 | 294,467 | ||
| 2026-03-02 | Willard Stephen H Chief Executive Officer | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2026-01-02 | Agafonova Nataliya Chief Medical Officer | Shares withheld for taxes | −10,250 | $0.59 | $6K | 216,564 |
| 2026-01-02 | Lehr Paul T General Counsel, Secretary | Shares withheld for taxes | −6,952 | $0.59 | $4K | 344,177 |
Page 2 of 7 · 123 trades